Cytarabine (Liposomal)

Records for this ingredient, by country (identity only).

ATC L01BC01 · 4 markets · 35 records

Cytarabine (Liposomal) 4 markets · 35 records Forms
Filters
MarketAU 17HK 14GB 2TW 2
Kind

AU 17 records · 8 shown of 8 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

Only this ingredient

  • 100 mg per mL / per unit basis not statedinjectionCYTARABINE ACC cytarabine 100 mg/5 mL injection vialCYTARABINE ACCORD cytarabine 4000 mg/40 mL injection vial、CYTARABINE JUNO 100 mg/5 mL solution for injection vial、CYTARABINE-ARX 100 mg/5 mL solution for injection vial、Pfizer (Australia) CYTARABINE 100mg/5mL injection vial unknown
  • 2,000 mg per mL / per unit basis not statedinjectionCYTARABINE ACCORD cytarabine 4000 mg/40 mL injection vialCYTARABINE JUNO 100 mg/5 mL solution for injection vial、CYTARABINE-ARX 100 mg/5 mL solution for injection vial、Pfizer (Australia) CYTARABINE 100mg/5mL injection vial unknown
  • 500 mg per mL / per unit basis not statedinjectionCYTARABINE ACCORD cytarabine 4000 mg/40 mL injection vialPfizer (Australia) CYTARABINE 100mg/5mL injection vial unknown
  • 1,000 mg per mL / per unit basis not statedinjectionCYTARABINE ACCORD cytarabine 4000 mg/40 mL injection vialPfizer (Australia) CYTARABINE 100mg/5mL injection vial unknown
  • 5,000 mg per mL / per unit basis not statedinjectionCYTARABINE ACCORD cytarabine 4000 mg/40 mL injection vial unknown
  • 4,000 mg per mL / per unit basis not statedinjectionCYTARABINE ACCORD cytarabine 4000 mg/40 mL injection vial unknown
  • 40 mg per mL / per unit basis not statedinjectionCYTARABINE ACC cytarabine 100 mg/5 mL injection vial unknown

Combination products containing this ingredient

  • 100 mg per mL / per unit basis not statedinjection CombinationCytarabine (Liposomal) 100 mg + Daunorubicin (Liposomal) 44 mgVYXEOS daunorubicin (as hydrochloride) 44 mg and cytarabine 100 mg powder for injection vial unknown

HK 14 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

14 records · 0 manufacturers 14 registros · 0 fabricantes 14 个记录 · 0 个厂家 14 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ACCORD CYTARABINE SOLUTION FOR INJECTION/INFUSION 100MG/1ML ×36ALEXAN INJ 5% ×1CYTARABINE INJ 100MG/ML ×1CYTARABINE KABI SOLUTION FOR INJECTION OR INFUSION 100MG/1ML ×9CYTOSAR FOR INJ 500MG ×1CYTOSAR STERILE POWDER FOR INJ 100MG ×1TABINE INJ 20MG/ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

GB 2 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

  • 50 mg/5 mLinjectionDepoCyte 50mg/5ml suspension for injection vials

Combination products containing this ingredient

TW 2 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

Only this ingredient

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Cytarine Injection ×1思得靈注射液 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.